Protocols (Studies) in the CTN
Number Name
Status
CTN-0075 Physician-Pharmacist Collaboration in the Management of Patients with Opioid Use Disorder in development
CTN-0074 Primary Care Opioid Use Disorders (PROUD) Treatment Trial in development
CTN-0073-Ot Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network in development
CTN-0072-Ot Patient and System-Level Factors Associated with HEDIS AOD-IET Measure Performance Across Health Systems in development
CTN-0071-Ot Electronic Health Records Data Elements Research (EHR-DARE) in development
CTN-0070-Ot Interpretation and Implementation of Title 42 CFR Part 2 for Confidentiality of Patient Drug and Alcohol Use Records: NIDA CTN Stakeholder Snapshot in development
CTN-0069 Opioid Use Disorder in the Emergency Department in development
CTN-0068 Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT-2) for Methamphetamine Use Disorder in development
CTN-0067 Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES): Scale-Up in development
CTN-0066-Ot Opioid Use Disorders in Primary Care Settings: Linking EHRs with PDMP and National Death Index Data Systems in development
CTN-0065-Ot Evaluation of Drug Screening Implementation in Primary Care in development
CTN-0064 Linkage to Hepatitis C Virus (HCV) Care Among HIV/HCV Co-Infected Substance Users active
CTN-0063-S Gender Differences in the Interrelationships Between Sexual Abuse, Risky Sexual Behavior, and Anxiety-Depression in Treatment Efficacy and Drug Use Over Time Among Individuals with Substance Use Disorders active
CTN-0062-Ot A Phased-Implementation Feasibility and Proof-of-Concept Study to Assess Incorporating the NIDA CTN Common Data Elements into the Electronic Health Record in Large Primary Care Settings (CDE-EHR-PC) active
CTN-0061-Ot Kaiser Virtual Data Warehouse -- Prescription Opioid Users active
CTN-0059 Tobacco, Alcohol, Prescription Medications, and Substance Use/Misuse Brief Screen/Assessment Tool (TAPS Tool) completed
CTN-0057-Ot Screening, Brief Intervention, and Referral to Treatment in Primary Care (SBIRT-PC)
completed
CTN-0056-Ot Testing and Linkage to HIV Care in China: A Cluster Randomized Trial
completed
CTN-0055 Comparing Treatments for HIV-Positive Opioid Users in an Integrated Care Effectiveness Study (CHOICES)
completed
CTN-0054 Accelerated Development of Additive Pharmacotherapy Treatment (ADAPT) for Methamphetamine Use Disorder
completed
CTN-0053 Achieving Cannabis Cessation -- Evaluating N-Acetylcystein Treatment (ACCENT)
completed
CTN-0052 A Randomized Controlled Evaluation of Buspirone for Relapse-Prevention in Adults with Cocaine Dependence (BRAC)
completed
CTN-0051 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT)
active
  CTN-0051-A-1 Extended-Release Naltrexone vs. Buprenorphine for Opioid Treatment (X:BOT) Genetics Study active
  CTN-0051-A-2 Treatment-As-Usual Opioid Use Outcomes Following Discharge from Detoxification and Short-Term Residential Programs Affiliated with CTN-0051 active
CTN-0050 Long Term Follow-Up of START Patients
active
CTN-0049 Project HOPE: Hospital Visit as Opportunity for Prevention and Engagement for HIV-Infected Drug Users
completed
  CTN-0049-A-1 Examining the Patient Navigation Process for HIV and Substance Abuse Treatment completed
  CTN-0049-A-2 Utilization of the Electronic Medical Record to Assess and Predict 3-Day Readmission Risk Among HIV-Infected Inpatients Enrolled in CTN-0049 completed
CTN-0048 Cocaine Use Reduction with Buprenorphine (CURB)
completed
  CTN-0048-A-1 Pharmacogenetics of Buprenorphine/Naltrexone for Cocaine Dependence in CURB Study completed
CTN-0047 Screening, Motivational Assessment, Referral and Treatment in Emergency Departments (SMART-ED): Evaluation of Screening, Brief Intervention, Referral to Treatment (SBIRT) and Booster Session for Drug Use Patients Presenting for Treatment in the Emergency Department
completed
  CTN-0047-A-1 Site Influences on Treatment Effects - Screening, Motivational Assessment, Referral, and Treatment in Emergency Departments (SMART-ED)
completed
CTN-0046 Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant Dependence
completed
  CTN-0046-A-1 Site Influences on Treatment Effects - Smoking Cessation and Stimulant Treatment (S-CAST): Evaluation of the Impact of Concurrent Outpatient Smoking Cessation and Stimulant Treatment on Stimulant-Dependence Outcome
completed
CTN-0045-Ot Rates of HIV Testing and Barriers to Testing in African Americans Receiving Substance Abuse Treatment
completed
CTN-0044 Web Delivery of Evidence-Based, Psychosocial Treatment for Substance Use Disorders
completed
  CTN-0044-A-1 Site Influences on Treatment Effects - Web-Delivery of Evidence-Based Psychosocial Treatment for Substance Use Disorders
completed
  CTN-0044-A-2 Acceptability of a Web-Delivered, Evidence-Based, Psychosocial Intervention Among Individuals with Substance Use Disorders Who Identify as American Indian/Alaska Native
completed
  CTN-0044-A-3 Web-Tx Organizational and Practitioner Follow-Up completed
CTN-0043-S Substance Abuse Treatment Outcomes in Racial/Ethnic Minority Populations
completed
CTN-0042-S Efficacy of Motivational Enhancement Therapy for African Americans
completed
CTN-0041-S Relationships Between Demographic Characteristics of Patients and Therapists, Measures of Therapeutic Process and Therapeutic Alliance, and Outcomes
completed
CTN-0040-S Pattern of Alcohol Use and Alcohol-Related Diagnoses among Drug Abusing/Dependent Participants
completed
CTN-0039-S Gender Differences in the Prevalence and Predictors of HIV Risk Behaviors
completed
CTN-0038-Ot Barriers to Substance Abuse Treatment Among Asian Americans and Pacific Islanders
completed
CTN-0037 Stimulant Reduction Intervention Using Dosed Exercise (STRIDE)
completed
  CTN-0037-A-1 Site Influences on Treatment Effects - Exercise as a Treatment for Substance Use Disorders completed
CTN-0036-Ot Epidemiology and Ethnographic Survey of "Cheese" Heroin Use among Hispanics in Dallas County
completed
CTN-0035-Ot Access to HIV and Hepatitis Screening and Care Among Ethnic Minority Drug Users In and Out of Drug Treatment
completed
CTN-0034-Ot Developing Research Capacity and Culturally Appropriate Research Methods: Community-Based Participatory Research Manual for Collaborative Research in Drug Abuse for American Indians and Alaska Natives
active
CTN-0033-Ot Methamphetamine Use Among American Indians completed
 
CTN-0033-Ot-1
Methamphetamine Use Among American Indians
completed
 
CTN-0033-Ot-2
Methamphetamine Use and Treatment in Native American Communities in the Southwest
completed
 
CTN-0033-Ot-3
Methamphetamine: Where Does It Fit in the Bigger Picture of Drug Use of American Indian and Alaska Native Communities and Treatment Seekers?
completed
 
CTN-0033-Ot-4
An Exploration of Methamphetamine and Other Drug Use and Treatment Options Among Urban and Rural Northern Plains American Indians
completed
 
CTN-0033-Ot-5
The Choctaw Nation Methamphetamine Data Needs Project
completed
CTN-0032 HIV Rapid Testing and Counseling
completed
 
CTN-0032-A-1
Economic Analysis of HIV Rapid Testing in Drug Abuse Treatment Programs
completed
 
Project
Aware
Project Aware: HIV Rapid Testing & Counseling in STD Clinics in the U.S. -- An Adaptation of CTN-0032
 
CTN-0031

Stimulant Abuser Groups to Engage in 12-Step (STAGE-12): Evaluation of a Combined Individual-Group Intervention to Reduce Stimulant and Other Drug Use by Increasing 12-Step Involvement

completed
 
CTN-0031-A-1
An Evaluation of Neurocognitive Function, Oxidative Damage, and Their Association with Treatment Outcomes in Methamphetamine and Cocaine Abusers
completed
 
CTN-0031-A-2
The Role of Alcohol Consumption in Classifications of Alcohol Use Disorders: A Clinical Study
completed
 
CTN-0031-A-3
Organizational and Practitioner Influences on Implementation of STAGE-12
completed
CTN-0030

Prescription Opioid Addiction Treatment Study (POATS)

completed
 
CTN-0030-A-1
Collection of Economic Data for the Prescription Opioid Addiction Treatment Study
completed
 
CTN-0030-A-2
Effects of Chronic Opioids on the Brain
completed
 
CTN-0030-A-3
Protocol Amendment to Examine Long-Term Outcomes
completed
CTN-0029

A Pilot Study of Osmotic-Release Methylphenidate in Initiating and Maintaining Abstinence in Smokers with ADHD

completed
CTN-0028

Osmotic-Release Methylphenidate for ADHD in Adolescents with Substance Use Disorders

completed
 
CTN-0028-A-1
Does Methylphenidate Treatment for ADHD Increase the Rate of Smoking in Adolescents with Comorbid ADHD, Substance Use Disorder, and Nicotine Dependence?
completed
CTN-0027

Starting Treatment with Agonist Replacement Therapies (START)

completed
 
CTN-0027-A-1
START Pharmacogenetics: Exploratory Genetic Studies in Starting Treatment with Agonist Replacement Therapies
completed
 
CTN-0027-A-2
Retention of Suboxone Patients in START: Perspectives of Providers and Patients
completed
CTN-0021

Motivational Enhancement Treatment to Improve Treatment Engagement and Outcomes for Spanish-Speaking Individuals Seeking Treatment for Substance Abuse

completed
CTN-0020

Job Seekers Training for Patients with Drug Dependence

completed
 
CTN-0020-A-1
Job Seekers' Training for Clients/Relatives with Drug Dependence (Specific to the Na'Nizhoozhi Center, Inc.)
completed
CTN-0019

Reducing HIV/STD Risk Behaviors: A Research Study for Women in Drug Abuse Treatment

completed
CTN-0018

Reducing HIV/STD Risk Behaviors: A Research Study for Men in Drug Abuse Treatment

completed
CTN-0017

HIV and HCV Intervention in Drug Treatment Settings

completed
CTN-0016

Patient Feedback: A Performance Improvement Study in Outpatient Addiction Treatment Settings

completed
CTN-0015

Women's Treatment for Trauma and Substance Use Disorders

completed
 
CTN-0015-A-1
Survey of Eating Disorder Symptoms among Women in Treatment for Substance Abuse Disorders
completed
CTN-0014

Brief Strategic Family Therapy for Adolescent Drug Abusers

completed
 
CTN-0014-A-1
Mediators and Moderators of BSFT for Adolescent Drug Use
completed
CTN-0013

Motivational Enhancement Therapy to Improve Treatment Utilization and Outcome in Pregnant Substance Users

completed
 
CTN-0013-A-1
Trauma and Intravenous Drug Use among Pregnant Alcohol/Other Drug Abusing Women: Factors in Predicting Child Abuse Potential
completed
CTN-0012

Characteristics of Screening, Evaluation, and Treatment of HIV/AIDS, Hepatitis C Viral Infections, and Sexually Transmitted Infections in Substance Abuse Treatment Programs

completed
CTN-0011

A Feasibility Study of a Telephone Enhancement Procedure (TELE) to Improve Participation in Continuing Care Activities

completed
CTN-0010

Buprenorphine/Naloxone-Facilitated Rehabilitation for Opioid Dependent Adolescents/Young Adults

completed
 
CTN-0010-A-1
Cost-Effective Analysis (CEA) in the CTN: Bup/Nal Treatment for Opioid Addicted Youth
completed
 
CTN-0010-A-2
Comorbid Conditions in Adolescents with Opioid versus Alcohol/Marijuana Use Disorders
completed
CTN-0009

Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy in Substance Abuse Rehabilitation Programs

completed
CTN-0008

Assessment of the National Drug Abuse Clinical Trials Network: A Baseline for Investigating Diffusion of Innovation

completed
CTN-0007

Motivational Incentives for Enhanced Drug Abuse Recovery: Methadone Clinics

completed
 
CTN-0007-A-1
Survey of Counselor's Perceptions of Incentive Programs
completed
 
CTN-0007-A-2
Economic Evaluations in the CTN -- Methods & Applications
completed
CTN-0006

Motivational Incentives for Enhanced Drug Abuse Recovery: Drug Free Clinics

completed
CTN-0005

MI (Motivational Interviewing) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

completed
CTN-0004

MET (Motivational Enhancement Treatment) to Improve Treatment Engagement and Outcome in Subjects Seeking Treatment for Substance Abuse

completed
CTN-0003

Suboxone (Buprenorphine/Naloxone) Taper: A Comparison of Taper Schedules

completed
CTN-0002

Buprenorphine/Naloxone versus Clonidine for Outpatient Opiate Detoxification

completed
CTN-0001

Buprenorphine/Naloxone versus Clonidine for Inpatient Opiate Detoxification



completed
Supported by a grant from the National Institute on Drug Abuse to the University of Washington Alcohol and Drug Abuse Institute.
The materials on this site have neither been created nor reviewed by NIDA.
Updated 10/2016 -- http://ctndisseminationlibrary.org/protocols.htm
info@ctndisseminationlibrary.org